Global Serological Transplant Diagnostics Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Serological Transplant Diagnostics Market Research Report 2024
Serological transplant diagnostics are used for all types of transplants. The products are developed based on the agglutination and complement fixation technology.
According to MRAResearch’s new survey, global Serological Transplant Diagnostics market is projected to reach US$ 405.7 million in 2033, increasing from US$ 345.5 million in 2022, with the CAGR of 2.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Serological Transplant Diagnostics market research.
Chronic kidney disease increases the risk of cardiovascular disease (CVD) and end-stage kidney renal disease (ESRD). The recent years witnessed a rise in the number of kidney transplantation procedures. The reduction in the average cost of gene sequencing will positively influence the growth of the human leukocyte antigen (HLA) typing market in the kidney transplantation segment. Additionally, the emergence of advanced serological diagnostic technologies will also boost the adoption of kidney transplantation procedures and will aid in serological transplant diagnostics market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Serological Transplant Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Bio-Rad Laboratories
Immucor
Siemens Healthineers
Ortho Clinical Diagnostics
Thermo Fisher Scientific
Agena Bioscience
AVIOQ
BAG Healthcare
BD
Beckman Coulter
Biogenuix
DIAGAST
Grifols
Hemo bioscience
Institut de Biotechnologies
Lorne Laboratories
MTC Invitro
Quotient Biodiagnostics
Tulip Group
Segment by Type
Kidney Transplantation
Liver Transplantation
Heart Transplantation
Lung Transplantation
Pancreas Transplantation
Hospitals, Blood Banks and Transplant Centers
Donor Registries and Research Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Serological Transplant Diagnostics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Serological Transplant Diagnostics market is projected to reach US$ 405.7 million in 2033, increasing from US$ 345.5 million in 2022, with the CAGR of 2.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Serological Transplant Diagnostics market research.
Chronic kidney disease increases the risk of cardiovascular disease (CVD) and end-stage kidney renal disease (ESRD). The recent years witnessed a rise in the number of kidney transplantation procedures. The reduction in the average cost of gene sequencing will positively influence the growth of the human leukocyte antigen (HLA) typing market in the kidney transplantation segment. Additionally, the emergence of advanced serological diagnostic technologies will also boost the adoption of kidney transplantation procedures and will aid in serological transplant diagnostics market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Serological Transplant Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bio-Rad Laboratories
Immucor
Siemens Healthineers
Ortho Clinical Diagnostics
Thermo Fisher Scientific
Agena Bioscience
AVIOQ
BAG Healthcare
BD
Beckman Coulter
Biogenuix
DIAGAST
Grifols
Hemo bioscience
Institut de Biotechnologies
Lorne Laboratories
MTC Invitro
Quotient Biodiagnostics
Tulip Group
Segment by Type
Kidney Transplantation
Liver Transplantation
Heart Transplantation
Lung Transplantation
Pancreas Transplantation
Segment by Application
Hospitals, Blood Banks and Transplant Centers
Donor Registries and Research Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Serological Transplant Diagnostics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source